Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy
Krzysztof Kiryluk,Elena Sanchez-Rodriguez,Xu-Jie Zhou,Francesca Zanoni,Lili Liu,Nikol Mladkova,Atlas Khan,Maddalena Marasa,Jun Y. Zhang,Olivia Balderes,Simone Sanna-Cherchi,Andrew S. Bomback,Pietro A. Canetta,Gerald B. Appel,Jai Radhakrishnan,Hernan Trimarchi,Ben Sprangers,Daniel C. Cattran,Heather Reich,York Pei,Pietro Ravani,Kresimir Galesic,Dita Maixnerova,Vladimir Tesar,Benedicte Stengel,Marie Metzger,Guillaume Canaud,Nicolas Maillard,Francois Berthoux,Laureline Berthelot,Evangeline Pillebout,Renato Monteiro,Raoul Nelson,Robert J. Wyatt,William Smoyer,John Mahan,Al-Akash Samhar,Guillermo Hidalgo,Alejandro Quiroga,Patricia Weng,Raji Sreedharan,David Selewski,Keefe Davis,Mahmoud Kallash,Tetyana L. Vasylyeva,Michelle Rheault,Aftab Chishti,Daniel Ranch,Scott E. Wenderfer,Dmitry Samsonov,Donna J. Claes,Oleh Akchurin,Dimitrios Goumenos,Maria Stangou,Judit Nagy,Tibor Kovacs,Enrico Fiaccadori,Antonio Amoroso,Cristina Barlassina,Daniele Cusi,Lucia Del Vecchio,Giovanni Giorgio Battaglia,Monica Bodria,Emanuela Boer,Luisa Bono,Giuliano Boscutti,Gianluca Caridi,Francesca Lugani,GianMarco Ghiggeri,Rosanna Coppo,Licia Peruzzi,Vittoria Esposito,Ciro Esposito,Sandro Feriozzi,Rosaria Polci,Giovanni Frasca,Marco Galliani,Maurizio Garozzo,Adele Mitrotti,Loreto Gesualdo,Simona Granata,Gianluigi Zaza,Francesco Londrino,Riccardo Magistroni,Isabella Pisani,Andrea Magnano,Carmelita Marcantoni,Piergiorgio Messa,Renzo Mignani,Antonello Pani,Claudio Ponticelli,Dario Roccatello,Maurizio Salvadori,Erica Salvi,Domenico Santoro,Guido Gembillo,Silvana Savoldi,Donatella Spotti,Pasquale Zamboli,Claudia Izzi,Federico Alberici,Elisa Delbarba,Michał Florczak,Natalia Krata,Krzysztof Mucha,Leszek Pączek,Stanisław Niemczyk,Barbara Moszczuk,Malgorzata Pańczyk-Tomaszewska,Malgorzata Mizerska-Wasiak,Agnieszka Perkowska-Ptasińska,Teresa Bączkowska,Magdalena Durlik,Krzysztof Pawlaczyk,Przemyslaw Sikora,Marcin Zaniew,Dorota Kaminska,Magdalena Krajewska,Izabella Kuzmiuk-Glembin,Zbigniew Heleniak,Barbara Bullo-Piontecka,Tomasz Liberek,Alicja Dębska-Slizien,Tomasz Hryszko,Anna Materna-Kiryluk,Monika Miklaszewska,Maria Szczepańska,Katarzyna Dyga,Edyta Machura,Katarzyna Siniewicz-Luzeńczyk,Monika Pawlak-Bratkowska,Marcin Tkaczyk,Dariusz Runowski,Norbert Kwella,Dorota Drożdż,Ireneusz Habura,Florian Kronenberg,Larisa Prikhodina,David van Heel,Bertrand Fontaine,Chris Cotsapas,Cisca Wijmenga,Andre Franke,Vito Annese,Peter K. Gregersen,Sreeja Parameswaran,Matthew Weirauch,Leah Kottyan,John B. Harley,Hitoshi Suzuki,Ichiei Narita,Shin Goto,Hajeong Lee,Dong Ki Kim,Yon Su Kim,Jin-Ho Park,BeLong Cho,Murim Choi,Ans Van Wijk,Ana Huerta,Elisabet Ars,Jose Ballarin,Sigrid Lundberg,Bruno Vogt,Laila-Yasmin Mani,Yasar Caliskan,Jonathan Barratt,Thilini Abeygunaratne,Philip A. Kalra,Daniel P. Gale,Ulf Panzer,Thomas Rauen,Jürgen Floege,Pascal Schlosser,Arif B. Ekici,Kai-Uwe Eckardt,Nan Chen,Jingyuan Xie,Richard P. Lifton,Ruth J. F. Loos,Eimear E. Kenny,Iuliana Ionita-Laza,Anna Köttgen,Bruce A. Julian,Jan Novak,Francesco Scolari,Hong Zhang,Ali G. Gharavi
DOI: https://doi.org/10.1038/s41588-023-01422-x
IF: 30.8
2023-06-20
Nature Genetics
Abstract:IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751 controls across 17 international cohorts. We defined 30 genome-wide significant risk loci explaining 11% of disease risk. A total of 16 loci were new, including TNFSF4/TNFSF18 , REL , CD28 , PF4V1 , LY86 , LYN , ANXA3 , TNFSF8/TNFSF15 , REEP3 , ZMIZ1 , OVOL1/RELA , ETS1 , IGH , IRF8 , TNFRSF13B and FCAR . The risk loci were enriched in gene orthologs causing abnormal IgA levels when genetically manipulated in mice. We also observed a positive genetic correlation between IgAN and serum IgA levels. High polygenic score for IgAN was associated with earlier onset of kidney failure. In a comprehensive functional annotation analysis of candidate causal genes, we observed convergence of biological candidates on a common set of inflammatory signaling pathways and cytokine ligand–receptor pairs, prioritizing potential new drug targets.
genetics & heredity